SCHEMBL11821935

SCHEMBL11821935

O=C(O)c1ccc(S(=O)(=O)N2CCCCC2)cc1SCc1cccc(Cl)c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 4/20 0.60
▸ TSHR P16473 2/20 0.56
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ CYP3A4 P08684 2/20 0.52
▸ PTPRC P08575 1/20 0.48
▸ LMNA P02545 4/20 0.48
▸ MAPT P10636 2/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ MITF O75030 1/20 0.48
▸ HTT P42858 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11817881 0.93 L3MBTL1 (0.59) L3MBTL1TSHRMEN1KMT2AALDH1A1
SCHEMBL11820807 0.80 TDP1 (0.56) L3MBTL1MEN1KMT2APTPRCMAPT
SCHEMBL11822234 0.80 L3MBTL1 (0.57) L3MBTL1TSHRMEN1KMT2AALDH1A1
SCHEMBL11819446 0.80 CYP3A4 (0.59) L3MBTL1TSHRMEN1KMT2ACYP3A4
SCHEMBL11820641 0.75 AKR1C3 (0.52) PTPRCLMNAMAPT
SCHEMBL11565647 0.75 AR (0.64) KMT2APTPRCHTT
SCHEMBL11817067 0.74 HSD17B10 (0.58) L3MBTL1TSHRMEN1KMT2AALDH1A1
SCHEMBL13802463 0.74 PTPRG (0.70) L3MBTL1MEN1KMT2APTPRCGAA
SCHEMBL11815191 0.73 TSHR (0.53) L3MBTL1TSHRMEN1KMT2AALDH1A1
SCHEMBL1708867 0.73 TSHR (1.00) L3MBTL1TSHRMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3954994-A Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents PFIZER INC. (US) 1976-05-04 — — US disclosed
Send feedback